Hosted on MSN1mon
Nanozyme targets hypoxic lesions to enhance radiosensitivity in nasopharyngeal carcinomaSubsequently, by extensively screening thousands of proteins in a cell surface protein database, they identified transferrin receptor 1 (TfR1) as highly expressed in NPC and closely associated ...
JCR’s proprietary J-Brain Cargo technology relies on a transferrin receptor-targeting antibody to deliver effector proteins into the CNS (Fig. 1). By binding to transferrin receptors on BBB ...
Inatherys SAS recently presented preclinical data for INA-03, an anti-transferrin receptor (TfR1/CD71) antibody-drug conjugate (ADC), being developed for the treatment of triple-negative breast cancer ...
“We are developing peptide and nanobody vectors that bind to well-defined receptors expressed by cells lining the BBB that facilitate the entry of essential nutrients such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results